Theranos Serves as a Cautionary Tale for Biotech Funding Post author:Sam Post published:March 15, 2018 Post category:BioPharma There are dangers in biotech funding and Theranos should serve as a warning. Source: BioSpace You Might Also Like J&J Bows Out of Race for Pfizer's $20B Consumer Health Biz January 25, 2018 AstraZeneca Plots Crucial IDO Phase III Combo Trial With Incyte October 30, 2017 Suitors Take Note as Bay Area's Nektar May Be Up for Sale February 4, 2018
